Wrinkles aren't where
ageing begins.

Ellansé is a collagen-stimulating injectable used to restore deeper facial support and improve facial contour.

Rather than simply filling an empty space to create volume, Ellansé can be strategically placed to act more like a supporting pillar underneath the facial tissues while stimulating collagen over time.

Ellansé contains PCL microspheres suspended in a CMC gel.

After treatment, it provides structural support while the PCL component gradually stimulates the body to produce new collagen.

This allows the treatment to provide support first, followed by progressive collagen improvement over time.

Ellansé is a collagen-stimulating injectable and is used differently from conventional HA fillers.

A simple way to understand the difference is:

• HA filler can be used to fill, shape or restore volume.
• Ellansé is commonly used by Dr. CK more like a supporting pillar, placed strategically to rebuild deeper facial support while stimulating collagen over time.

The choice depends on what the face actually needs.

Ellansé may be useful when the face has lost deeper structural support, projection or definition.

Instead of simply adding volume where the face looks hollow or saggy, Dr. CK may use Ellansé strategically to rebuild support from underneath.

Depending on the individual facial structure, it may be used as part of a treatment plan for facial lifting, structural support and precise facial contouring.

Dr. CK commonly uses Ellansé for deeper facial support and precise contouring in selected areas such as:

• brow
• zygoma / cheekbone
• nose bridge
• side cheek
• jawline
• chin

Its relatively low water-attracting property is one reason Dr. CK particularly values Ellansé for maintaining clean and defined facial contours.

The areas treated depend on the individual's facial structure and treatment objective.

Structural improvement may be noticeable soon after treatment, while collagen stimulation develops progressively over the following months.

How long the result lasts varies between individuals and depends on factors such as the treatment area, facial movement, ageing process and treatment plan.

The aim is not simply to create temporary volume, but to restore appropriate support and allow collagen improvement to develop over time.

There is no fixed number.

The amount required depends on factors such as:

• facial structure
• degree of support loss
• treatment areas
• previous aesthetic treatments
• intended result

At Agness Clinic, the treatment plan is designed after assessing the whole face rather than prescribing the same number of syringes for every patient.

They are different tools for different purposes.

HA dermal filler comes in the widest range of textures and firmness, from very soft and flexible products to much firmer products.

Because of this variety, HA fillers are extremely versatile and can be used across almost every part of the face.

Depending on the product selected, a doctor may use:

• softer HA fillers for delicate areas and subtle correction
• medium-consistency HA fillers for volume restoration and shaping
• firmer HA fillers when stronger projection or structural support is required

This wide range allows HA fillers to address areas and treatment needs that may not be suitable for other injectable categories, including biostimulators such as Ellansé and Radiesse, or collagen-based injectables such as Dusederm and Karisma.

Ellansé serves a different role in Dr. CK's approach.

Rather than simply filling a space to create volume, Ellansé is commonly placed deeper and used like a structural pillar to provide support while stimulating collagen over time.

Therefore, it is not simply a question of whether Ellansé or HA filler is better.

The more important question is what that particular part of your face needs:

volume, support, contouring, collagen stimulation — or a combination.

Both stimulate collagen, but their physical characteristics are very different, so Dr. CK uses them for different purposes.

Ellansé has a firmer, mouldable consistency.

In Dr. CK's approach, it is commonly placed in deeper facial layers where stronger support is required. This makes it particularly useful for lifting and precise contouring of areas such as the brow, cheekbone, nose bridge, jawline and chin.

Sculptra is different.

It is prepared as a diluted injectable rather than a firm, mouldable product. Dr. CK therefore commonly uses it more superficially, including within the facial fat layer, when the objective is broader collagen stimulation, skin firming and tightening rather than creating a defined contour.

A simple way to understand their roles is:

• Ellansé builds deeper support and contour.
• Sculptra helps improve more superficial firmness and tightening.

For a face showing ageing changes at different tissue levels, these treatments do not necessarily compete with each other.

When both deeper support loss and more superficial collagen loss are present, different treatments may be combined to address the different layers for a more complete and natural result.

Not everyone experiencing facial ageing needs Ellansé.

During consultation, Dr. CK first assesses:

• your main concern
• your previous aesthetic treatments
• the outcome of those treatments
• your expectations
• your facial structure
• your individual ageing pattern

The visible problem may have more than one underlying cause.

Only after understanding these factors is a treatment strategy designed.

Ellansé may be appropriate for deeper structural support or contouring, another treatment may be more suitable, or several treatments may need to be combined or performed in stages.

The treatment should follow what your face needs — not which product is currently trending.

The cost of Ellansé treatment depends on the number of syringes required, the areas being treated and the overall treatment plan.

At Agness Clinic, the amount is determined after facial assessment rather than using the same number of syringes for every patient. The recommended treatment plan and total cost are confirmed during consultation.

Temporary injection-site effects such as swelling, redness, tenderness or bruising may occur after treatment and usually settle with time.

Treatment safety is also influenced by appropriate patient selection, a detailed understanding of facial anatomy, correct product placement and the injector’s level of experience.

Careful assessment and precise technique can help minimise avoidable risks and support a safer, more predictable treatment outcome. Individual suitability should always be assessed by the treating doctor before treatment.